AU2003226725A8 - Pyrazolopyrimidine derivatives - Google Patents

Pyrazolopyrimidine derivatives

Info

Publication number
AU2003226725A8
AU2003226725A8 AU2003226725A AU2003226725A AU2003226725A8 AU 2003226725 A8 AU2003226725 A8 AU 2003226725A8 AU 2003226725 A AU2003226725 A AU 2003226725A AU 2003226725 A AU2003226725 A AU 2003226725A AU 2003226725 A8 AU2003226725 A8 AU 2003226725A8
Authority
AU
Australia
Prior art keywords
pyrazolopyrimidine derivatives
pyrazolopyrimidine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU2003226725A
Other versions
AU2003226725A1 (en
Inventor
Jason Witherington
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2003226725A1 publication Critical patent/AU2003226725A1/en
Publication of AU2003226725A8 publication Critical patent/AU2003226725A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU2003226725A 2002-03-27 2003-03-25 Pyrazolopyrimidine derivatives Abandoned AU2003226725A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0207246.0A GB0207246D0 (en) 2002-03-27 2002-03-27 Novel compounds
GB0207246.0 2002-03-27
PCT/EP2003/003196 WO2003080617A1 (en) 2002-03-27 2003-03-25 Pyrazolopyrimidine derivatives

Publications (2)

Publication Number Publication Date
AU2003226725A1 AU2003226725A1 (en) 2003-10-08
AU2003226725A8 true AU2003226725A8 (en) 2003-10-08

Family

ID=9933830

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003226725A Abandoned AU2003226725A1 (en) 2002-03-27 2003-03-25 Pyrazolopyrimidine derivatives

Country Status (3)

Country Link
AU (1) AU2003226725A1 (en)
GB (1) GB0207246D0 (en)
WO (1) WO2003080617A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009506069A (en) 2005-08-26 2009-02-12 ブレインセルス，インコーポレイティド Neurogenesis through modulation of muscarinic receptors
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
AU2006304787A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
BRPI0706610A2 (en) * 2006-01-18 2011-04-05 Siena Biotech Spa nicotinically acetylcholine alpha 7 receptor modulators and therapeutic uses of these
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593997A (en) * 1995-05-23 1997-01-14 Pfizer Inc. 4-aminopyrazolo(3-,4-D)pyrimidine and 4-aminopyrazolo-(3,4-D)pyridine tyrosine kinase inhibitors
AU4878601A (en) * 2000-04-20 2001-11-07 Mitsubishi Corporation Aromatic amide compounds
JP2004509891A (en) * 2000-09-22 2004-04-02 スミスクライン　ビーチャム　パブリック　リミテッド　カンパニー Pyrazolopyridine and pyrazolopyridazine as antidiabetic drugs
US7105532B2 (en) * 2000-12-19 2006-09-12 Smithkline Beecham Corporation Pyrazolo[3,4-c]pyridines as gsk-3 inhibitors
GB0100621D0 (en) * 2001-01-10 2001-02-21 Vernalis Res Ltd Chemical compounds VI

Also Published As

Publication number Publication date
AU2003226725A1 (en) 2003-10-08
WO2003080617A1 (en) 2003-10-02
GB0207246D0 (en) 2002-05-08
WO2003080617A8 (en) 2003-11-13

Similar Documents

Publication Publication Date Title
AP2005003342A0 (en) Pyrrolopyrimidine derivatives
AP1850A (en) Spiroindolineplperidine derivatives
EG24050A (en) Heterocylocarboxamide derivatives
HK1077068A1 (en) Azolidinone-vinyl fused-benzene derivatives
IL166121A0 (en) Indole-3-sulphur derivatives
EP1522540A4 (en) Azaarene derivatives
PL376475A1 (en) N-substituted-2-oxodihydropyridine derivatives
ZA200500471B (en) N-biarylmethyl aminocycloalkanecarboxamide derivatives
GB0416511D0 (en) Pyrrolobenzodiazepines
HK1099302A1 (en) Pyrazolo and imidazo-pyrimidine derivatives
HK1088900A1 (en) Pyrrolopyridazine derivatives
IL172592A0 (en) Pyrazolopyrimidines
ZA200509884B (en) 6-Cyclylmethyl- and 6-alkylmethyl-substituted pyrazolopyrimidines
PL372047A1 (en) Pyrrolopyrimidine derivatives
PL372989A1 (en) Triazolopyrimidines
AU2003222659A8 (en) 23-o-substituted 5-o-mycaminosyltylonide derivatives
AU2003215676A1 (en) Pyrazolopyrimidines derivatives
EP1513537A4 (en) Substituted porphyrins
GB0227259D0 (en) Porphyrin derivatives
AU2003226725A8 (en) Pyrazolopyrimidine derivatives
EP1531854A4 (en) O-derivatized nocathiacin derivatives
ZA200510374B (en) Pyrazolopyrimidines
TWI350836B (en) 6-cyclylmethyl- and 6-alkylmethyl-substituted pyrazolopyrimidines
GB0213488D0 (en) 2-Naphthamide derivatives
GB0310123D0 (en) Airfreshener combined luminair

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase